ResearcherFred and Pamela Buffett Cancer CenterNo recent work listed
Divya Thomas
Matched on OpenAlex author ID A5109245089. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 16
2019: 4 papers · 2020: 1 paper · 2021: 2 papers
Papers 7
- MUC4 enhances gemcitabine resistance and malignant behaviour in pancreatic cancer cells expressing cancer-associated short O-glycans. Co-author DOI 10.1016/j.canlet.2021.01.015↗
- Isoforms of MUC16 activate oncogenic signaling through EGF receptors to enhance the progression of pancreatic cancer. Co-author DOI 10.1016/j.ymthe.2020.12.029↗
- Role of Tumor and Stroma-Derived IGF/IGFBPs in Pancreatic Cancer. Co-author DOI 10.3390/cancers12051228↗
- The glycoprotein mucin-1 negatively regulates GalNAc transferase 5 expression in pancreatic cancer. Co-author DOI 10.1002/1873-3468.13532↗
- Truncated O-glycans promote epithelial-to-mesenchymal transition and stemness properties of pancreatic cancer cells. Co-author DOI 10.1111/jcmm.14572↗
- A Polymeric Nanogel-Based Treatment Regimen for Enhanced Efficacy and Sequential Administration of Synergistic Drug Combination in Pancreatic Cancer. First author DOI 10.1124/jpet.118.255372↗
- Tumor-stromal crosstalk in pancreatic cancer and tissue fibrosis. Co-author DOI 10.1186/s12943-018-0927-5↗
Closest collaborators
The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Prakash Radhakrishnan · 7 shared papers, 2019–2021 · strength 0.99
- Paper Role of Tumor and Stroma-Derived IGF/IGFBPs in Pancreatic Cancer. DOI 10.3390/cancers12051228↗
- Paper Tumor-stromal crosstalk in pancreatic cancer and tissue fibrosis. DOI 10.1186/s12943-018-0927-5↗
- Paper MUC4 enhances gemcitabine resistance and malignant behaviour in pancreatic cancer cells expressing cancer-associated sh… DOI 10.1016/j.canlet.2021.01.015↗
- Thomas C. Caffrey · 5 shared papers, 2019–2021 · strength 0.55
- Paper MUC4 enhances gemcitabine resistance and malignant behaviour in pancreatic cancer cells expressing cancer-associated sh… DOI 10.1016/j.canlet.2021.01.015↗
- Paper Truncated O-glycans promote epithelial-to-mesenchymal transition and stemness properties of pancreatic cancer cells. DOI 10.1111/jcmm.14572↗
- Paper The glycoprotein mucin-1 negatively regulates GalNAc transferase 5 expression in pancreatic cancer. DOI 10.1002/1873-3468.13532↗
- Satish Sagar · 5 shared papers, 2019–2021 · strength 0.55
- Paper MUC4 enhances gemcitabine resistance and malignant behaviour in pancreatic cancer cells expressing cancer-associated sh… DOI 10.1016/j.canlet.2021.01.015↗
- Paper Truncated O-glycans promote epithelial-to-mesenchymal transition and stemness properties of pancreatic cancer cells. DOI 10.1111/jcmm.14572↗
- Paper The glycoprotein mucin-1 negatively regulates GalNAc transferase 5 expression in pancreatic cancer. DOI 10.1002/1873-3468.13532↗
- Michael Anthony Hollingsworth · 4 shared papers, 2019–2021 · strength 0.43
- Paper MUC4 enhances gemcitabine resistance and malignant behaviour in pancreatic cancer cells expressing cancer-associated sh… DOI 10.1016/j.canlet.2021.01.015↗
- Paper The glycoprotein mucin-1 negatively regulates GalNAc transferase 5 expression in pancreatic cancer. DOI 10.1002/1873-3468.13532↗
- Paper Isoforms of MUC16 activate oncogenic signaling through EGF receptors to enhance the progression of pancreatic cancer. DOI 10.1016/j.ymthe.2020.12.029↗
- Paul M. Grandgenett · 2 shared papers, 2019–2021 · strength 0.22
- Paper Truncated O-glycans promote epithelial-to-mesenchymal transition and stemness properties of pancreatic cancer cells. DOI 10.1111/jcmm.14572↗
- Paper Isoforms of MUC16 activate oncogenic signaling through EGF receptors to enhance the progression of pancreatic cancer. DOI 10.1016/j.ymthe.2020.12.029↗
- Kyle L. McAndrews · 1 shared paper, 2021 · strength 0.13
- Premila Devi Leiphrakpam · 1 shared paper, 2021 · strength 0.13
- Xiang Liu · 1 shared paper, 2021 · strength 0.10
- H. Carlo Maurer · 1 shared paper, 2021 · strength 0.10
- Jen Jen Yeh · 1 shared paper, 2021 · strength 0.10
- Kenneth P. Olive · 1 shared paper, 2021 · strength 0.10
- Kamiya Mehla · 1 shared paper, 2019 · strength 0.09
- Kruti S. Soni · 1 shared paper, 2019 · strength 0.09
- Subodh M. Lele · 1 shared paper, 2019 · strength 0.09
- Fan Lei · 1 shared paper, 2019 · strength 0.09
- Tatiana K. Bronich · 1 shared paper, 2019 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.